A law firm, Sidley, is guiding a $2.1bn collaboration involving radiopharmaceuticals with Telix. The details of the collaboration are not specified, but it is reportedly valued at $2.1bn. Other law firms are involved in separate deals, including one in Korea and another in Australia, but their connection to the Telix collaboration is unclear.